Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
1988 | Receptor binding studies of human interleukin-2 mutant proteins. | Lee, N; Liang, SM | | | | |
2012 | Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting alpha5beta1 integrin to down-regulate Akt and MMP-2. | Peng, JM; Chen, YH; Hung, SW; Chiu, CF; Ho, MY; Lee, YJ; Lai, TC; Hsiao, M; Liang, CM; Liang, SM | BRITISH JOURNAL OF PHARMACOLOGY 165(2), 479-493 | | | |
2012 | Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting α5β1 integrin to downregulate Akt and MMP-2 | Peng, JM; Chen, YH; Hung, SW; Chiu, CF; Ho, MY; Lee, YJ; Lai, TC; Hsiao, M; Liang, CM ; Liang, SM | BRITISH JOURNAL OF PHARMACOLOGY 165(2), 479-493 | | | |
2011 | Recombinant viral protein suppresses metastasis of ovarian adenocarcinoma cells through negative Akt signaling. | Peng, JM; Hung, SW; Chiu, CF; Ho, MY; Hsiao, M; Liang, CM; Liang, SM | | | | |
2012 | Recombinant Viral Protein VP1 Suppresses HER-2 Expression and Migration/Metastasis of Breast Cancer | Hung, SW; Chiu, CF; Chen, TA; Chu, CL; Huang, CC; Shyur, LF; Liang, CM; Liang, SM | BREAST CANCER RESEARCH AND TREATMENT 136(1), 89-105 | | | |
2015 | Recombinant vp1 of FMDV differentially regulates motility of cancer cells and macrophages. | Liang, CM; Liao, CC; Liang, SM | | | | |
2015 | Recombinant VP1 regulates motility of cancer cells and macrophages differentially via let-7a and MMP-9. | Liang, CM; Liao, CC; Liang, SM | | | | |
2011 | Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production. | Chen, TA; Wang, JL; Hung, SW; Chu, CL; Cheng, YC; Liang, SM | PLoS One 6(8), e23317 | | | |
2016 | Refolded albumin inhibits IL17Bdriven pancreatic cancer migration. | Liang, CM; Liao, CC; Liang, SM | | | | |
1990 | Regulation by glutathione (GSH) of the activation of clCD-3 induced activated killer cells (CD3-AK). | Hargrove, ME; Liang, SM; Liang, CM; Ting, CC | | | | |
1992 | Regulation by glutathione of interleukin-4 activity on cytotoxic T cells | Liang, SM; Lee, N; Finbloom, D; Liang, CM | IMMUNOLOGY 75: 435-440 | | | |
2015 | Regulation of aldo-keto-reductase family 1 B10 by 14-3-3epsilon and their prognostic impact of hepatocellular carcinoma. | Liu, TA; Jan, YJ; Ko, BS; Wu, YJ; Lu, YJ; Liang, SM; Liu, CC; Chen, SC; Wang, J; Shyue, SK; Liou, JY | Oncotarget 6(36), 38967-38982 | | | |
1992 | Regulation of biological materials by FDA | Liang, CM; Liang, SM | Regulation of biological materials by FDA (Washington DC : CCNAA) | | | |
1989 | Regulation of the binding and internalization of IL-2 by glutathione. | Liang, SM; Lee, N; Cattell, D; Liang, CM | | | | |
1990 | Regulation of theexpression and turnover of interleukin-2 receptors by glutathione. | Liang, SM; Epstein, J; Lee, N; Liang, SM | | | | |
1991 | Relationship between glutathione and interleukin-2 dependency of cytotoxic T cells. | Liang, CM; Liang, SM | | | | |
1999 | Research and Development of DNA Vaccine. | Liang, SM | | | | |
2013 | Retinoic acid-elicited RARα/RXRα signaling attenuates Aβ production by directly inhibiting γ-secretase-mediated cleavage of amyloid precursor protein | Kapoor, A; Wang, BJ; Hsu, WM; Chang, MY; Liang, SM; Liao, YF | ACS Chemical Neuroscience In Press | | | |
2015 | Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells. | Cheng, YT; Yeih, DF; Liang, SM; Chien, CY; Yu, YL; Ko, BS; Jan, YJ; Kuo, CC; Sung, LY; Shyue, SK; Chen, MF; Yet, SF; Wu, KK; Liou, JY | International journal of cardiology 201, 441-448 | | | |
1985 | Role of tryptophan 121 in 1nterleukin-2 structure and function. | Thatcher, DR; Liang, SM; Allet, B | | | | |